Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches

Colorectal cancer (CRC) represents 10% of all cancer types, making it the third leading cause of cancer-related deaths globally. Metastasis is the primary factor causing mortality in CRC patients. Approximately 22% of CRC-related deaths have metastasis present at diagnosis, with approximately 70% of...

Full description

Bibliographic Details
Main Authors: Furong Li, Yanping Lin, Rong Li, Xin Shen, Mengying Xiang, Guangrui Xiong, Ke Zhang, Tingrong Xia, Jiangyan Guo, Zhonghui Miao, Yedan Liao, Xuan Zhang, Lin Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Pharmacology
Subjects:
colorectal cancer
molecular targeted therapy
VEGF
epidermal growth factor receptor
RAS
Her-2
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1165666/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1165666/full

Similar Items